Anthony Clare


Anthony is a corporate partner specialising in M&A and corporate finance. He covers a range of sectors, with particular market recognition in life sciences and biotechnology.

Anthony advises on a wide range of corporate matters including M&A (public and private), joint ventures and equity capital markets. He has acted on over 20 IPOs in the London market, with a particular bias towards issuer-side mandates. He is well known in the biotech industry, and serves as the deputy chair of the Babraham Institute, Cambridge – one of Europe’s leading bioscience research institutes.

Anthony is named as a 'star' in the corporate section of the 2015 edition of LMG Life Sciences and listed in the Top 50 European M&A lawyers 2014 by Global M&A Network (EMEA).